当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › NEUROPEPTIDES杂志
NEUROPEPTIDES
基本信息
期刊名称 NEUROPEPTIDES
NEUROPEPTIDES
期刊ISSN 0143-4179
期刊官方网站 http://www.journals.elsevier.com/neuropeptides/
是否OA
出版商 Churchill Livingstone
出版周期 Bimonthly
始发年份 1980
年文章数 66
最新影响因子 2.9(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 ENDOCRINOLOGY & METABOLISM 内分泌学与代谢4区
NEUROSCIENCES 神经科学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.52 0.818 0.743
Neuroscience
Endocrine and Autonomic Systems
11 / 24 56%
Biochemistry, Genetics and Molecular Biology
Endocrinology
53 / 118 55%
Neuroscience
Neurology
61 / 148 59%
Neuroscience
Cellular and Molecular Neuroscience
61 / 85 28%
补充信息
自引率 9.20%
H-index 63
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0143-4179%5BISSN%5D
投稿指南
期刊投稿网址 http://ees.elsevier.com/npep/default.asp?pg=preRegistration.asp
收稿范围

The aim of Neuropeptides is the rapid publication of original research and review articles, dealing with the structure, distribution, actions and functions of peptides in the central and peripheral nervous systems. The explosion of research activity in this field has led to the identification of numerous naturally occurring endogenous peptideswhich act as neurotransmitters, neuromodulators, or trophic factors, to mediate nervous system functions. Increasing numbers of non-peptide ligands of neuropeptide receptors have been developed, which act as agonists or antagonists in peptidergic systems.

The journal provides a unique opportunity of integrating the many disciplines involved in all neuropeptide research. The journal publishes articles on all aspects of the neuropeptide field, with particular emphasis on gene regulation of peptide expression, peptide receptor subtypes, transgenic and knockout mice with mutations in genes for neuropeptides and peptide receptors, neuroanatomy, physiology, behaviour, neurotrophic factors, preclinical drug evaluation, clinical studies, and clinical trials.

Original papers predominate. Manuscripts may be of any length, but must be complete studies; preliminary communications are not accepted. Review articles and hypothesis papers are welcomed, and will be evaluated in the same way as experimental papers. Authors intending to submit a review are advised to communicate their intentions to the Editor, to avoid possible duplication.

收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息
Editor

H. Herzog

Garvan Institute of Medical Research, Sydney, New South Wales, Australia
Special Editor for Review Articles

B. Kofler

Salzburg, Austria
Editorial Board

S.D. Brain

London, United Kingdom

J.B. Calixto

Florianópolis, Brazil

C.-Y. Chen

Taipei, Taiwan

M.A. Cline

Radford, Virginia, United States

W.F. Colmers

Edmonton, Alberta, Canada

J.N. Crawley

Sacramento, California, United States

A.L. Gundlach

Parkville, Australia

M. Heilig

Stockholm, Sweden

T. Hokfelt

Stockholm, Sweden

A. Inui

Kagoshima, Japan

T. Karl

Sydney, New South Wales, Australia

M.J. Kuhar

Atlanta, Georgia, United States

E. Pinter

Pecs, Hungary

B. Przewlocka

Krakow, Poland

J. Quinn

Liverpool, United Kingdom

R. Quirion

Montréal, Quebec, Canada

A. Ribeiro-da-Silva

Montréal, Quebec, Canada

R.J. Rodgers

Leeds, United Kingdom

R. Tasan

Innsbruck, Austria

B.K. Taylor

Lexington, Kentucky, United States

T.E. Thiele

Chapel Hill, North Carolina, United States

T. Yada

Shimotsuke, Japan


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug